Objectives: To evaluate predictive values of serum amyloid A (SAA) and C-reactive protein (CRP) for infection and mortality in patients with febrile neutropenia (FEN).
INTRODUCTION
In spite of advantages in prophylactic and empirical antimicrobial therapy, unrecognised or ineffectively treated infections are common causes of death in patients with prolonged chemotherapy-induced neutropenia. The diagnosis of neutropenic infection is difficult. Inadequate presentation of clinical and radiological signs of neutropenic infections may delay the diagnosis of life-threatening infections. 1, 2 Fever in a neutropenic patient may be the first and the only sign of infection. Because of that, immediate empirical broad-spectrum antibiotherapy has become a common practice in the management of patients with febrile neutropenia (FEN). 3 Moreover, this approach may result in both ineffective treatment in some patients and overtreatment in others. As a matter of fact, microbiologically or clinically defined infections have been documented in only 60% of cases. Therefore, reliable parameters are necessary for description of infections causing FEN. 4 Serum and plasma concentrations of mediators related to infection such as acute phase reactants or cytokines are thought to reflect the presence of microbial pathogens. The determination of such mediators may support the early diagnosis of infections. Therefore, highly specific and sensitive markers indicating infection early in the course are being investigated. [5] [6] [7] [8] Concentrations of several acute-phase proteins [C-reactive protein (CRP), serum amyloid A (SAA), procalcitonin], proinflammatory cytokines [tumor-necrosis factor-alpha (TNF-α), interleukin (IL)-1, IL-6, IL-8, interferon (IFN)-g] and soluble adhesion molecules (intercellular adhesion molecule 1, vascular cell adhesion molecule 1, soluble E-selectin) in the serum have been investigated for their contribution to identify the infectious cause of FEN. However, data regarding the significance of proinflammatory cytokines, CRP, and soluble adhesion molecules in the clinical evaluation of FEN is quite limited in the medical literature. Furthermore, the predictive values of those parameters for decision of initial antimicrobial therapy in patients with FEN is quite low. Also, they had limited value to predict outcome in cancer patients. 9, 10 Elevated CRP has been reported to be a predictor of lower survival rates after surgical resection in patients with malignancy (eg: lung, gastrointestinal, urinary and genital tract cancers). It may serve as a prognostic predictor for survival and posttreatment monitoring in cancer patients. 11, 12 SAA, an acute-phase protein synthesized predominantly by liver, may rise up to 1000-fold during acute inflammation. It has been shown to activate the inflammatory pathway, and may have a role in immunomodulation. 13 SAA is found to be more sensitive than CRP for the indication of some of advanced cancers. 14 In one of our previous studies in which we investigated various risk factors in febrile neutropenic patients, we had found that the CRP levels in the first 48 hours of FEN episode were significant for prediction of infection (p=0.001) but insignificant for prediction of mortality (p=0.595). 15 In this prospective study, we intended to evaluate the value of mainly SAA for earlier prediction of infection and mortality, and its correlation with CRP.
METHODS
Patients. Adult cancer patients with FEN who were followed and treated in the Medical Oncology and the Radiation Oncology departments of Kartal Dr. Lütfi Kırdar Training and Research Hospital, were hospitalized in the Infectious Diseases Department. We enrolled 65 FEN episodes of a total of 52 patients of ages between 15 and 77 in a prospective study for a year. Written informed consent of the patients was obtained before enrolment. FEN is defined as a single oral temperature of ≥38.3°C or ≥38°C lasting for ≥1h within 24 hours in patients with absolute neutrophil count (ANC) ≤500/mm 3 or between 500 and 1000/mm 3 and expected to decrease within 24-48 hours in absence of blood or blood product transfusion or cytotoxic therapy. 3 Patients having ANC never <500/mm 3 and neutropenia without fever and those having fever related to transfusion of blood or blood products were excluded.
Initial evaluation of patients with FEN included a complete medical history, thorough physical examination (involving skin, oropharynx, perianal region and catheter-entry sites) and various laboratory tests. At least two blood specimens 30 minutes apart, urine and specimens from other appropriate body sites suspected to be the focus of infection according to signs and symptoms were obtained immediately for culture and urgent empirical antimicrobial therapy was started. Blood cultures were performed in an automated system (BacTec, Becton-Dickinson, USA). Measurement of complete blood count, CRP, SAA, erythrocyte sedimentation rate (ESR), standard blood chemistry, a complete urine analysis and chest radiography were made within 24 h of the onset of fever. Additional necessary measurements and cultures were done during the study period. Blood samples for complete blood count, CRP and SAA were obtained daily until the end of the antibiotherapy. The following characteristics of the patients and/or episodes were recorded: age, sex, type of malignity, Karnofsky performance status, 16, 17 body temperature and polymorhonuclear leukocyte (PNL) counts at the beginning of episode, presence of high risk factors, previous FEN episode, presence of comorbidities (pneumonia, diarrhea, severe mucositis, hypotension, cardiopulmonary insufficiency and/or any organ dysfunction) and complications during follow-up, use of colony-stimulating factor, transfusion of blood or blood products, duration of fever, duration of neutropenia, duration of antibiotherapy and response to empirical therapy.
The characteristics of high-risk group patients were defined as the following: presence of a hematological malignancy (lymphoma or acute leukemia), pneumonia, diarrhea severe mucositis, hypotension, cardiopulmonary insufficiency, or any organ dysfunction, neutropenia lasting ≥10 days and neutrophil count ≤ 100 /mm 3 , poor general appearance. Whereas, the characteristics of low-risk group patients were: neutropenia lasting < 10 days, polymorhonuclear leukocyte count > 100 /mm 3 , platelet count > 75.000 /mm 3 and good general appearance. 3 Empirically a b-lactam antibiotic with anti-pseudomonal activity (ceftazidime 2 g three times a day IV, piperacillin-tazobactam 4.5 g three times a day IV or cefepime 2 g twice a day IV or cefoperazonesulbactam 2 g twice a day) was administered initially. The initial empirical antibiotic therapy was chosen by of the admitting physician. Antimicrobial therapy was modified as needed when the infection was documented microbiologically or in case of persistance of fever. Antibiotherapy was discontinued after the patient had been afebrile for five days, at the time of neutrophil recovery (ANC >500/ mm 3 ) or after the signs of infection disappeared. Antifungal and/or antibacterial prophylaxis were not given to the patients.
Definition of a new FEN episode. Development of a new episode of FEN in a patient who had already recovered from a previous episode of FEN, had completed antimicrobial therapy and had received another cycle of chemotherapy and/or radiotherapy which caused neutropenia again. Accompanying comorbidity (eg: Diabetes mellitus, chronic renal failure, chronic obstructive pulmonary disease etc.) was present in 26 (40%) febrile episodes. Only six (11.5%) patients were in high-risk group, while the rest was in low-risk group. There were no patients with invasive aspergillosis (IA) based on clinical and radiological findings. Fiftysix (86.2%) episodes were cured without any complications. While 4 (6.2%) febrile episodes resulted in cure with complications (respiratory insufficiency, transfer to intensive care unit, confusion/ change in mental status, bleeding requiring transfusion, arrythmia requiring treatment, renal insufficiency, allergic reaction or fungal infection), 5 patients died during the course of therapy. Four of them died decause of severe sepsis and 1 because of possible progression of underlying malignancy.
Out of a total 26 infections, 23 were microbiologically and three were clinically defined, mortality was seen in only five cases. Of the total 65 episodes, 16 (24.6 %) had BI (six Staphylococcus aureus, three Streptococcus pneumoniae, two Pseudomonas spp., two Klebsiella spp., one Acinetobacter spp., one Enterobacter aerogenes, one Escherichia coli), seven (10.8 %) had MI (two S. aureus, two E. coli, two Klebsiella spp. and one Pseudomonas spp.), three CI (4.6%) and 39 (60%) had FUO.
The median duration of fever was 3 days (1-14 days). The median duration of neutropenia was 4 days (1-9 days). The median duration of antibiotherapy was 8 days (1-14 days) . The median CRP level at the beginning was 137 mg/L (range: 23 -420 mg/L) and the median SAA level was 547 mg/L (range: 11 -1660 mg/L). Statistically significant positive correlation was documented between the first-day SAA and CRP levels (p<0.01) and between the first-day SAA and CRP levels and Karnofsky scores (p=0.028 for SAA, p=0.034 for CRP). A statistically significant correlation was also determined between the median values of daily SAA ve CRP levels from the first day of the febrile episode till the twelfth day (p<0.05) (Figures 1 and 2 ). The sensitivity of SAA level greater than 80 mg/L was 100%, the positive (PPV) and the negative (NPV) predictive values for detection of infection were 48% and 100%, respectively. The specificity of SAA remained low even at cut-off level greter than 200 mg/L. The sensitivity of CRP level greater than 50 mg/L was 86%, the PPV and the NPV for detection of infection were 47% and 60%, respectively. The specificity of CRP also remained low ( Tables  2 and 3 ). When the predictive values of initial median SAA and CRP levels for the presence of infection (BI, MI and CI vs FUO) were examined, statistically significant difference was found only in CRP levels (p=0.015 for CRP; p=0.947 for SAA). Similar results were found also when the last-day SAA and CRP levels regarding infection were examined (p=0.054 for SAA; p=0.010 for CRP) (Figures 3 and 4) . The difference of SAA levels between days was more evident than CRP (c2=186 for SAA, c2 =153 for CRP). ROC curve to determine the accuracy of CRP and SAA in predicting infection was demonstrated in Figure 5 . Area under the curve (AUC) for CRP and SAA were 0.72 (p=0.003, 95% CI: 0.59-0.86) and 0.68 (p=0.019, 95% CI: 0.54-0.82), respectively. 
DISCUSSION
In patients with FEN, infection is the most important cause of mortality, fever should be considered as a sign of a life-threatening infection in neutropenic patients until any type of infection is excluded. and those patients should be managed accordingly. The patient who has signs and symptoms consistent with infection should be managed immediately and a number of diagnostic steps should be taken. Inadequate inflammatory response and inapperance of signs and symtoms of infection because of decreased neutrophil count causes a major difficulty in diagnosis. The only sign of infection in patients with severe neutropenia (PNL<100/ m3) is often fever. However, although the physical signs corresponding to the infectious focus are usually absent and the cause of fever is recognised in only 25-30% of cases in the last 10-15 years, physical examination should be made thoroughly.
Various markers which may contribute to diagnosis or exclusion of infections in patients with FEN have been investigated for years. An ideal parameter would rise before the documentation of significant microbiologic findings or would direct to further investigations to determine the focus of infection even in nonfebrile patients. Unfortunatelly, none of the proposed parameters has a major clinical relevance in the differential diagnosis of infectious and non-infectious causes of fever in neutropenic patients. Although studies using cytokines which are expensive have been made recently, their practical use seems to be limited. Among these, IL-6, which has been shown to increase earlier and to be a more sensitive marker, its sensitivity to predict bacterial infections for institution of initial therapy remained too low. Moreover, its predictive value and accuracy was equal to that of CRP. 18, 19 It was reported that the CRP levels above 40 mg/L in febrile neutropenic patients were closely related with infection, the probability of infection increased as it was elevated above 100 mg/L, and the elevation of CRP more than 50 mg/L within 24 hours follow-up had a positive predictive value of 95%. 20 Yonemori et al. showed CRP to be useful to monitor the response to therapy for febrile episodes in neutropenia. However, they failed to show statistically significant differrences in CRP levels between febrile episodes with or without clinically documented infection and with or without bacteremia. 21 Studies with CRP being more practical and cost-effective than cytokines are accepted as routine follow-up parameters in many centres. CRP level is used as a sensitive inflammation indicator in bacterial infections, but it shows only a minimal increase in acute viral infections. SAA, in contrast to CRP, followed the same elevation trend in both bacterial and viral infections. 22 SAA has been a useful inflammatory indicator in acute viral infections in which viral isolation is impossible and the differential diagnosis is difficult clinically. 23 The improvement of infection and the effectiveness of antimicrobial therapy are assessed by rapid decrease in SAA levels. 24, 25, 26 It has been reported that levels of both parameters increased in acute phase of infections, decreased in the convalescent phase, and disclosed a clear positive correlation with each other, 27 similar to our findings in this study. Compared to CRP, five to eleven times more increase was observed in SAA leves, which increased evidently in 98% of acute phase of viral infections. In contrast to our results, SAA was shown to disappear earlier than CRP. Riikonen et al have shown that the acute phase reactants CRP and SAA were elevated together in most episodes, but neither was definitive in differentiating between the categories of febrile episodes. 28 SAA was proved to be more sensitive than CRP for the early detection of bacteremia. No normal values of SAA were observed in the group with true bacteremia, as opposed to 32% of normal CRP values in bacteremia. 28 In one of our previous studies, we had found the CRP levels in the first 48 hours of FEN episode were significant for prediction of infection (p=0.001) but insignificant for prediction of mortality (p=0.595). 15 Taking these data into consideration, in this study we investigated the change in CRP and SAA levels on consecutive days measured by nephelometric immunoassay and we determined a clear correlation between SAA and CRP concordant with data in the literature despite the fact that SAA levels increased more in the first day of FEN episode. Initial (first-day) SAA and CRP levels were insignificant to predict infection and mortality. But a significant decrease in time was evident in all cases. Undetermined probable infections in the group of fever of unknown origin (FUO) could play a role in this consequence. When the initial and the last-day levels were compared, SAA seemed to be more sensitive than CRP. All of these results are consistent with previous data in the literature. The sensitivity and NPV of SAA for detection of infection was high (both are 100%) at the cutoff level 80 mg/L but the specificity of SAA remained low even at cutoff level greater than 200 mg/L. The specificity could increase if dilution procedure was applied in the nephelometric assay (that is to detect the exact levels greater than 200 mg/L) but that could not be cost-effective for every patient. The specificity of CRP for detection of infection also remained low. When the variation of SAA and CRP levels on the consecutive days was investigated; it was observed that both parameters had increased more on the second and the third day of the febrile episode than the first day, and decreased progressively later on and this decrease was statistically highly significant (Figures 1 and 2) . The difference of SAA levels between days was more evident than CRP. This result may be interpreted as SAA being a better predictor of the level of infection and inflammation and being more sensitive than CRP. AUC on the ROC curve for both CRP and SAA were nearly 0.7 which meant that they were fair tests with some uses in prediction of infection.
The prediction of mortality was not taken into consideration statistically; because of the low number (only 5) of mortal cases and the shortness of the duration of the follow-up. The levels of SAA and CRP in those four patients who died from sepsis were initially higher than the levels in patients who survived. The "prediction of mortality" mentioned as one of the intentions is evidently impossible due to severe underpowering.
According to the literature, predictive values of CRP, proinflammatory cytokines and soluble adhesion molecules seem to be too low to influence initial treatment decisions in patients with neutropenic fever. There were several limitations of the studies such as poor design and small size of the study population. Moreover, studies were heterogenous with respect to patients involved (children and adults, patients with hematologic malignancy and patients with solid tumors) and the different categories of febrile episodes compared. None of the investigators analyzed cost-effectiveness or impact of serial measurements of these parameters on patients' outcome. Furthermore, at present, no single multicenter trial has been published related to this issue. Therefore, it is difficult to draw general conclusions. More data are necessary to decide on the utility of those parameters in diagnosis of infection in neutropenic fever. Although none of the parameters proposed up to now has gained major clinical significance in diagnosis of etiology of neutropenic fever, SAA and CRP, which are more practical to determine and cheaper than cytokines, are proved once more to be significant parameters in the follow-up of FEN episodes in this study. Moreover, SAA was found to be more sensitive in the presence of infection.
Main weaknesses of our study are disclosed as the following: It has been reported that mortality in patient group with FUO could be significantly decreased by the early institution of broad-spectrum antibiotics. Calculations of sensitivity, specificity, PPV and NPV for detection of infection were presented in Tables 2 and 3 do not include those patients with FUO. In addition, the number of febrile neutropenic episodes is rather small to draw any valuable conclusion. Patients receiving blood-products should be rolled out per the definition by that such products could cause immunological fever. In a significant number of episodes, patients (47.7%) were transfused with blood-products during the study period. Itmay have an impact on the results.
CONCLUSION
Better-designed studies may provide results with higher predictive values with addition of new parameters. The significance of SAA and CRP in prediction of infection may increase with measurement of their levels in neutropenic patients before becoming febrile. In conclusion; despite low predictive values of these parameters in decision of initial antimicrobial therapy in febrile neutropenic patients, they would be helpful in decision of modification and evaluation of response to therapy.
